艾伯维CD123 ADC递交上市申请。#Seeking# #biotech#
$艾伯维公司(ABBV)$
AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment OptionsOptions.
原文，网页链接。$恒瑞医药(SH600276)$ $亚盛医药-B(06855)$